Mallory-Weiss syndrome laboratory findings: Difference between revisions
Mohamed Diab (talk | contribs) |
Mohamed Diab (talk | contribs) |
||
Line 2: | Line 2: | ||
{{Mallory-Weiss syndrome}} | {{Mallory-Weiss syndrome}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
Line 11: | Line 9: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Laboratory findings consistent with the diagnosis of Mallory-Weiss syndrome include decreased hemoglobin due to bleeding, thrombocytopenia due to bleeding and alcohol use, and elevated Blood urea nitrogen (BUN). | |||
==References== | ==References== |
Revision as of 17:08, 19 October 2017
Mallory-Weiss syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mallory-Weiss syndrome laboratory findings On the Web |
American Roentgen Ray Society Images of Mallory-Weiss syndrome laboratory findings |
Risk calculators and risk factors for Mallory-Weiss syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Blood tests, such as a complete blood count (CBC), blood chemistries, blood clotting tests, and liver function tests, are used to assess the condition of the patient.
BUN, creatinine, and electrolyte levels are measured to guide intravenous fluid therapy.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Mallory-Weiss syndrome include decreased hemoglobin due to bleeding, thrombocytopenia due to bleeding and alcohol use, and elevated Blood urea nitrogen (BUN).